Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / KROS - OraSure's Emergency Use Authorization And Other News: The Good Bad And Ugly Of Biopharma

KROS - OraSure's Emergency Use Authorization And Other News: The Good Bad And Ugly Of Biopharma

Keros Therapeutics Inc.
  • OraSure receives emergency use authorization for OMNIgene.
  • Keros Therapeutics initiates Phase 2 clinical trial for Myelodysplastic Syndromes.
  • Affimed to collaborate with NKMax America for SNK01 natural killer cell therapy.

For further details see:

OraSure's Emergency Use Authorization, And Other News: The Good, Bad And Ugly Of Biopharma
Stock Information
Company Name: Keros Therapeutics Inc.
Stock Symbol: KROS
Market: NASDAQ
Website: kerostx.com
Menu
KROS KROS Quote KROS Short KROS News KROS Articles KROS Message Board
Get KROS Alerts

News, Short Squeeze, Breakout and More Instantly...